PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab
Clinical trial NCT01131247 · WITHDRAWN
Trial details
- NCT number
- NCT01131247
- Sponsor
- Nevada Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.